- Home
- AEYE vs RCEL Comparison
AEYE vs RCEL Comparison
Compare AEYE & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEYE
- RCEL
- Stock Information
- Founded
- AEYE 2005
- RCEL N/A
- Country
- AEYE United States
- RCEL United States
- Employees
- AEYE N/A
- RCEL N/A
- Industry
- AEYE Computer Software: Prepackaged Software
- RCEL Medical/Dental Instruments
- Sector
- AEYE Technology
- RCEL Health Care
- Exchange
- AEYE Nasdaq
- RCEL Nasdaq
- Market Cap
- AEYE 138.0M
- RCEL 161.5M
- IPO Year
- AEYE N/A
- RCEL N/A
- Fundamental
- Price
- AEYE $11.81
- RCEL $5.19
- Analyst Decision
- AEYE Strong Buy
- RCEL Strong Buy
- Analyst Count
- AEYE 5
- RCEL 4
- Target Price
- AEYE $26.40
- RCEL $16.50
- AVG Volume (30 Days)
- AEYE 67.4K
- RCEL 287.8K
- Earning Date
- AEYE 07-24-2025
- RCEL 08-07-2025
- Dividend Yield
- AEYE N/A
- RCEL N/A
- EPS Growth
- AEYE N/A
- RCEL N/A
- EPS
- AEYE N/A
- RCEL N/A
- Revenue
- AEYE $36,851,000.00
- RCEL $71,661,000.00
- Revenue This Year
- AEYE $20.16
- RCEL $57.29
- Revenue Next Year
- AEYE $18.74
- RCEL $28.07
- P/E Ratio
- AEYE N/A
- RCEL N/A
- Revenue Growth
- AEYE 16.52
- RCEL 41.35
- 52 Week Low
- AEYE $8.91
- RCEL $5.10
- 52 Week High
- AEYE $34.85
- RCEL $14.16
- Technical
- Relative Strength Index (RSI)
- AEYE 46.36
- RCEL 29.07
- Support Level
- AEYE $11.27
- RCEL $5.10
- Resistance Level
- AEYE $12.17
- RCEL $6.33
- Average True Range (ATR)
- AEYE 0.57
- RCEL 0.32
- MACD
- AEYE -0.08
- RCEL 0.02
- Stochastic Oscillator
- AEYE 32.14
- RCEL 6.10
About AEYE AudioEye Inc.
AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. Trusted by the ADP, Tommy Hilfiger, A360 Media, Samsung, Landry's and others. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences.
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.